Risk of Depression after Parkinson’s disease, stroke, multiple sclerosis, and migraine in an Iranian population
Objective: We aim to evaluate the prevalence of depression in disorders including multiple sclerosis (MS), Parkinson's disease (PD), migraine, and stroke. Also, we detect risk…Real-world utility of MANAGE PD tool by physicians and patients in Germany
Objective: To investigate the utility of the MANAGE PD tool in routine clinical care in Germany and the planned next steps after the tool recommendation.…Correlation between oculometric measures, disease severity, and clinical assessment in patients with Parkinson’s disease
Objective: To evaluate the correlation between oculometric measures (OMs), disease severity, and clinical assessment in a cohort of patients with Parkinson’s disease (PD). Background: Oculometric…Testing for alcohol responsivity in familial essential tremor
Objective: In this study, we describe the alcohol response in our familial essential tremor cohort by employing the Knudsen-Lorenz-Deuschl test for alcohol responsivity outside its…Patient perspectives on symptoms and functional impacts to inform a digital assessment of Parkinson’s disease
Objective: The aim of this study is to map patients’ reports of functional limitations and impacts of Parkinson’s disease (PD) to motor signs captured with…Assessing non-motor symptoms and associations with quality of life among patients in Korle-Bu Teaching Hospital, Ghana
Objective: To determine the prevalence and types of non-motor symptoms (NMS) and their relation to quality of life among Parkinson’s disease (PD) patients who attend…using latent class mixed modelling to profile Parkinson’s disease patients at risk of cognitive decline
Objective: To determine the clinical profile of cognitive subtypes in Parkinson's disease (PD) based on their rate of change in global cognitive ability over time.…The Short Duration Response and Long Duration Response to L-Dopa are Needed to Restore Vigor-Motivation Coupling in Parkinson Disease
Objective: To assess the relationship between the Short Duration Response (SDR) and Long Duration Response (LDR) to L-Dopa therapy in Parkinson disease (PD) and restoration…Genetic and phenotypic characterization of ATX-FAT2 (SCA45) in three Indian families
Objective: Delineation of clinical and genetic features of Spinocerebellar ataxia 45 (SCA45) in three families of Indian origin. Background: SCA45 has been reported in few…Safety of foslevodopa/foscarbidopa during optimization and maintenance treatment: Post hoc analysis of a phase 3, single-arm trial
Objective: Evaluate the frequency of adverse events over time with foslevodopa/foscarbidopa (LDP/CDP) in patients with advanced Parkinson’s disease (PD) in a phase 3, open-label safety…
- « Previous Page
- 1
- …
- 84
- 85
- 86
- 87
- 88
- …
- 1374
- Next Page »